Therapeutic efficacy of trehalose eye drops for treatment of murine dry eye induced by an intelligently controlled environmental system

被引:0
|
作者
Li, Jinyang [1 ]
Roubeix, Christophe [2 ]
Wang, Yu [1 ]
Shi, Shuai [1 ]
Liu, Guoting [1 ]
Baudouin, Christophe [2 ,3 ,4 ]
Chen, Wei [1 ]
机构
[1] Wenzhou Med Coll, Sch Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China
[2] Univ Paris 06, INSERM, U968, Inst Vis, Paris, France
[3] Quinze Vingts Natl Ophthalmol Hosp, Dept Ophthalmol, Paris, France
[4] Univ Versailles St Quentin Yvelines, Ambroise Pare Hosp, AP HP, Versailles, France
来源
MOLECULAR VISION | 2012年 / 18卷 / 35-37期
基金
中国国家自然科学基金;
关键词
CORNEAL EPITHELIAL-CELLS; OCULAR SURFACE DISORDERS; DESICCATING STRESS; KERATOCONJUNCTIVITIS SICCA; BARRIER DISRUPTION; GENE-EXPRESSION; MOUSE MODEL; PROTECTS; DISEASE; CYTOKINE;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Purpose: To determine whether eye drop instillation of the disaccharide trehalose (TT) alleviates ocular surface damage in a dry eye murine model. Methods: Dry eye was induced in mice using an intelligently controlled environmental system (ICES). After 21 days housed in the ICES without topical treatment, the mice were randomly divided into three groups: no eye drops (ICES) for three weeks, four times a day with PBS 0.01 M 10 mu l/eye bilaterally (ICES+PBS), or with TT 87.6 mM 10 mu l/eye bilaterally (ICES+TT). Another mice group that was not exposed to the ICES and received no treatment served as a control group (UT). The ocular surface integrity, in each group, was evaluated using Oregon Green dextran (OGD) and fluorescein staining. The expression and distribution of occludin, involucrin, and small proline-rich protein 2 were determined with immunohistology analysis on whole mounted corneas. Heat shock protein 70 (HSP70) and matrix metalloproteinase 9 (MMP-9) expression was estimated with immunohistology. Ocular surface inflammation associated with each treatment was estimated with real time-PCR of interleukin-1 beta (IL-1 beta), IL-2, IL-6, IL-17, and tumor necrosis factor-alpha in the conjunctiva. Results: OGD staining in the cornea epithelium was lower in the ICES+TT group than in the ICES and ICES+PBS groups. Corneal epithelial occludin staining was markedly more homogenous in the ICES+TT group than in ICES and ICES+PBS groups, and there were no desquamating apical epithelial cells. Involucrin and small proline-rich protein 2 labeling of whole mounted corneas revealed upregulation of their expression in the groups, which received no treatment or PBS instillation compared to the ICES+TT group. HSP70 and MMP-9 immunolabeling revealed a marked increase in corneal epithelial expression in response to the ICES. The group treated with trehalose showed a similar profile expression of HSP70 and MMP-9 as the control group (UT). Conjunctival IL-1 beta, IL-2, IL-6, IL-17, tumor necrosis factor-alpha (TNF-alpha), and MMP-9 mRNA expression was lower in the ICES+TT group than in the ICES or ICES+PBS group. Conclusions: Trehalose application restored ocular surface integrity, suppressed inflammatory and proteolytic MMP-9 and HSP70 expression, and keratinization in mice with dry eye damaged by a desiccative model.
引用
收藏
页码:317 / 329
页数:13
相关论文
共 50 条
  • [1] A murine model of dry eye induced by an intelligently controlled environmental system
    Chen, Wei
    Zhang, Xiaobo
    Zhang, Jingna
    Chen, Jinpeng
    Wang, Shiming
    Wang, Qinmei
    Qu, Jia
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2008, 49 (04) : 1386 - 1391
  • [2] Trehalose eye drops in the treatment of dry eye syndrome
    Matsuo, T
    Tsuchida, Y
    Morimoto, N
    OPHTHALMOLOGY, 2002, 109 (11) : 2024 - 2029
  • [3] A murine model of dry eye induced by topical administration of erlotinib eye drops
    Yang, Qi-Chen
    Bao, Jing
    Li, Cheng
    Tan, Gang
    Wu, An-Hua
    Ye, Lei
    Ye, Lin-Hong
    Zhou, Qiong
    Shao, Yi
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2018, 41 (03) : 1427 - 1436
  • [4] Novel Eye Drops for the Treatment of Dry Eye Disease
    Lasowski, Frances
    Muirhead, Ben B.
    Hicks, Emily Anne
    Rambarran, Talena
    Liu, Lina
    Sheardown, Heather
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [5] A review of the efficacy, safety and tolerability of Lacrycon® eye drops for the treatment of dry eye syndrome
    Heitzmann, M. Eberle
    Thumm, D.
    Baudouin, C.
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2019, 42 (06): : 642 - 654
  • [6] Randomized controlled trial on the efficacy and safety of autologous serum eye drops in dry eye syndrome
    Zheng, Na
    Zhu, Si-Quan
    WORLD JOURNAL OF CLINICAL CASES, 2023, 11 (28) : 6774 - 6781
  • [7] Efficacy of the Diquafosol Sodium and Tocopherol Acetate (Vitamin E) Mixture Eye Drops in Murine Dry Eye
    Li, Lan
    Jin, Rujun
    Li, Ying
    Yoon, Hee Su
    Kim, Jong Hwa
    Yoon, Hyeon Jeong
    Yoon, Kyung Chul
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [8] Therapeutic Efficacy of Topical Epigallocatechin Gallate in Murine Dry Eye
    Lee, Hyun Soo
    Chauhan, Sunil K.
    Okanobo, Andre
    Nallasamy, Nambi
    Dana, Reza
    CORNEA, 2011, 30 (12) : 1465 - 1472
  • [9] Efficacy of Osmoprotectants on Prevention and Treatment of Murine Dry Eye
    Chen, Wei
    Zhang, Xin
    Li, Jinyang
    Wang, Yu
    Chen, Qi
    Hou, Chao
    Garrett, Qian
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (09) : 6287 - 6297
  • [10] Cytisine eye drops for benzalkonium chloride-induced dry eye: safety and efficacy evaluation
    Wang, Zijian
    Song, Xixi
    Wei, Yanjun
    Wu, Xianggen
    Jie, Ying
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2024, 29 (05) : 457 - 467